BioCentury | Jan 6, 2017
Finance

Good riddance

...Ltd. (KOSDAQ:196300) 12/7/16 $11.3 $76.7 $56.4 -26% SillaJen Inc. (KOSDAQ:215600) 12/6/16 $135.0 $831.8 $653.1 -21% FutureChem Co. Ltd....
BioCentury | Dec 9, 2016
Financial News

FutureChem completes IPO

...W15,000 in an IPO underwritten by NH Investment & Securities. FutureChem Co. Ltd. (KOSDAQ:220100), Seoul, South Korea Alicia Parker FutureChem Co. Ltd....
BioCentury | Feb 25, 2008
Company News

Bayer, FutureChem Co. Ltd. deal

...Bayer's Bayer Schering Pharma AG division received exclusive, worldwide rights to FutureChem's fluorine-18 (F-18) radiolabeling technology...
...disease and for treatment monitoring. Financial terms were not disclosed. Bayer AG (FSE:BAY), Leverkusen, Germany FutureChem Co. Ltd....
Items per page:
1 - 3 of 3
BioCentury | Jan 6, 2017
Finance

Good riddance

...Ltd. (KOSDAQ:196300) 12/7/16 $11.3 $76.7 $56.4 -26% SillaJen Inc. (KOSDAQ:215600) 12/6/16 $135.0 $831.8 $653.1 -21% FutureChem Co. Ltd....
BioCentury | Dec 9, 2016
Financial News

FutureChem completes IPO

...W15,000 in an IPO underwritten by NH Investment & Securities. FutureChem Co. Ltd. (KOSDAQ:220100), Seoul, South Korea Alicia Parker FutureChem Co. Ltd....
BioCentury | Feb 25, 2008
Company News

Bayer, FutureChem Co. Ltd. deal

...Bayer's Bayer Schering Pharma AG division received exclusive, worldwide rights to FutureChem's fluorine-18 (F-18) radiolabeling technology...
...disease and for treatment monitoring. Financial terms were not disclosed. Bayer AG (FSE:BAY), Leverkusen, Germany FutureChem Co. Ltd....
Items per page:
1 - 3 of 3